Table 2.
Cytokine levels in tear of COVID-19 patients compared to controls.
| Cytokines | Control group (n = 41) | COVID-19 (n = 62) | p |
|---|---|---|---|
| IL-1RA | 10219.12 ± 20072.36 | 12497.95 ± 18423.12 | 0.562 |
| IL-4 | 3.16 ± 5.17 | 3.11 ± 5.13 | 0.960 |
| IL-6 | 10.71 ± 17.28 | 54.87 ± 245.28 | 0.163 |
| IL-8 | 423.47 ± 1222.22 | 331.45 ± 777.89 | 0.670 |
| IL-9 | 30.02 ± 73.43 | 79.91 ± 74.15 | 0.001** |
| IL-15 | 742.02 ± 1702.32 | 2575.88 ± 2726.65 | <0.001** |
| IL-17A | 24.43 ± 25.52 | 15.56 ± 18.94 | 0.061 |
| Eotaxin | 11.55 ± 22.33 | 2.68 ± 8.39 | 0.019* |
| G-CSF | 248.51 ± 427.92 | 543.19 ± 781.12 | 0.015* |
| GM-CSF | 5.1 ± 13.83 | 18.42 ± 27.33 | 0.002** |
| IFN-γ | 77.21 ± 110.71 | 154.65 ± 197.1 | 0.012* |
| IP-10 | 24494.77 ± 37384.68 | 13882.07 ± 42887.93 | 0.187 |
| MIP-1a | 7.82 ± 7.47 | 8.73 ± 18.75 | 0.732 |
| PDGF | 127.58 ± 237.44 | 242.75 ± 310.92 | 0.036* |
| RANTES | 75.4 ± 52.21 | 71.39 ± 41.89 | 0.681 |
| VEGF | 1571.6 ± 3146.13 | 4141.32 ± 4387.04 | 0.001** |
Data are expressed as mean (pg/mL) ± standard deviation (SD). * (p < 0.05); ** (p < 0.01).